SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CollaGenex (CGPI) FDA PENDING
CGPI 0.00010000.0%Jul 21 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: patlew who wrote (39)10/5/1998 9:49:00 PM
From: Richard Haugland  Read Replies (2) of 142
 
I hope it will be a money maker, of course. I just got in for the first time today at 10 1/4 after hearing ot CGPI's drop post FDA approval a couple of days ago on another board. I was not expecting my order to get filled so soon but the market was really dismal today. Sell on the news I guess. With only 8.59 million shares outstanding

biz.yahoo.com

I like the prospects of the company developing a good EPS in a relatively short time. I needed some variety from the 15 other stock I have been buying and losing money on, so don't count on me to bring good luck to this stock.

I guess that they can take away the "pending" from the FDA pending on this site. I don't know enough about the company yet to project or analyze their returns but I would expect that there should be some adjustment in their expected revenues and earnings for future quarters not that they have received FDA approval. Does anyone know what type of revenues are expected from sales of Periostat? Certainly the problem of periodontal disease is a big one.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext